Friday, July 10, 2026

pharma · Pompe Disease (Late-onset) · Fabry Disease

Pacalis Therapeutics Pty

Pacalis Therapeutics Pty patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

melbourne, AU HQ
2023 Founded
1 Employees
TGA registrant Type
Company details
Status
Public
HQ
melbourne, AU
Founded
2023
Employees
1
Programs
5
Drugs
6
Patents
0
Intelligence · Patents

Pacalis Therapeutics Pty patents

0 pharmaceutical patents indexed for Pacalis Therapeutics Pty. 0 expire within 24 months.

Pacalis Therapeutics Pty has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Pacalis Therapeutics Pty have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Pacalis Therapeutics Pty patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.